LABD vs. ARKK
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and ARKK (ARK Innovation ETF) are both exchange-traded funds - LABD is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (-300%), while ARKK is a Technology Equities fund actively managed by ARK. LABD is passively managed, while ARKK is actively managed. Over the past 10 years, LABD returned -56.11%/yr vs 15.75%/yr for ARKK. At a correlation of -0.71, they often move in opposite directions. LABD charges 1.06%/yr vs 0.75%/yr for ARKK.
Performance
LABD vs. ARKK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -29.83% return, which is significantly lower than ARKK's 1.61% return. Over the past 10 years, LABD has underperformed ARKK with an annualized return of -56.11%, while ARKK has yielded a comparatively higher 15.75% annualized return.
LABD
- 1D
- -4.73%
- 1M
- 4.70%
- YTD
- -29.83%
- 6M
- -31.22%
- 1Y
- -80.27%
- 3Y*
- -49.85%
- 5Y*
- -41.45%
- 10Y*
- -56.11%
ARKK
- 1D
- -2.19%
- 1M
- -0.09%
- YTD
- 1.61%
- 6M
- -3.21%
- 1Y
- 34.90%
- 3Y*
- 23.72%
- 5Y*
- -6.26%
- 10Y*
- 15.75%
LABD vs. ARKK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -29.83% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
ARKK ARK Innovation ETF | 1.61% | 35.49% | 8.40% | 69.04% | -66.97% | -23.60% | 152.71% | 35.08% | 3.52% | 87.33% |
Correlation
The correlation between LABD and ARKK is -0.57, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.57 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.64 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.71 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.72 |
Correlation (All Time) Calculated using the full available price history since May 29, 2015 | -0.71 |
The correlation between LABD and ARKK shifts across timeframes, from -0.72 (10 years) to -0.57 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. ARKK — Risk / Return Rank
LABD
ARKK
LABD vs. ARKK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and ARK Innovation ETF (ARKK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABD | ARKK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.03 | ||
| Sortino ratioReturn per unit of downside risk | -3.74 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 1.17 | -0.42 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 1.12 | -2.08 |
| Martin ratioReturn relative to average drawdown | -1.31 | 2.49 | -3.80 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LABD | ARKK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.06 | 0.96 | -2.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.43 | -0.14 | -0.30 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.59 | 0.39 | -0.98 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.54 | 0.35 | -0.89 |
Drawdowns
LABD vs. ARKK - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than ARKK's maximum drawdown of -80.97%. Use the drawdown chart below to compare losses from any high point for LABD and ARKK.
Loading charts...
Drawdown Indicators
| LABD | ARKK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -80.97% | -19.02% |
Max Drawdown (1Y)Largest decline over 1 year | -83.21% | -31.35% | -51.86% |
Max Drawdown (3Y)Largest decline over 3 years | -95.31% | -39.56% | -55.75% |
Max Drawdown (5Y)Largest decline over 5 years | -98.24% | -77.23% | -21.01% |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | -80.97% | -19.01% |
Current DrawdownCurrent decline from peak | -99.99% | -49.39% | -50.60% |
Average DrawdownAverage peak-to-trough decline | -90.92% | -30.12% | -60.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.36% | 14.06% | +47.30% |
Volatility
LABD vs. ARKK - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 27.46% compared to ARK Innovation ETF (ARKK) at 9.45%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than ARKK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | ARKK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.46% | 9.45% | +18.01% |
Volatility (6M)Calculated over the trailing 6-month period | 61.67% | 25.08% | +36.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.77% | 36.37% | +39.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.26% | 46.28% | +49.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.93% | 40.26% | +55.67% |
LABD vs. ARKK - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than ARKK's 0.75% expense ratio.
Dividends
LABD vs. ARKK - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 6.45%, while ARKK has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKK ARK Innovation ETF | 0.00% | 0.00% | 0.00% | 0.70% | 0.00% | 0.55% | 1.64% | 0.38% | 3.14% | 1.32% | 0.00% | 2.27% |
LABD Direxion Daily S&P Biotech Bear 3x Shares | 6.45% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
LABD and ARKK have a correlation of -0.57, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (27.46%) compared to ARKK (9.45%). In terms of maximum drawdown, LABD dropped -99.99% vs ARKK's -80.97%.
On 10-year performance, ARKK leads with 15.75% vs -56.11% for LABD. On fees, ARKK is cheaper at 0.75% per year. On volatility, ARKK has been the lower-risk option at 9.45%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, ARKK has performed better with a 15.75% return vs -56.11%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKK is cheaper with a 0.75% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 6.45%, compared with 0.00% for ARKK.
LABD is categorized as Leveraged Equities, while ARKK is Technology Equities. They also come from different issuers: Direxion and ARK. Their fees differ too: 1.06% for LABD and 0.75% for ARKK.
ARKK currently has the higher Sharpe Ratio (0.96 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and ARKK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer